Abstract
In 2013, systemic therapy has been introduced in the treatment of local advanced (laBCC) and metastatic basal cell carcinoma (mBCC). Meanwhile, immuno......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
